What Aussie parents need to know about meningococcal disease
Read more - What Aussie parents need to know about meningococcal disease Read more
Press releases
These press releases are intended for business journalists and analysts/investors
The three letters making Australian men disappear
INTERNATIONAL MEN’S HEALTH WEEK
- Life interrupted for Australian men as 1 in 3 over 50 affected by BPH
- New Prostate Health campaign urges men affected to consult GP
Read more - The three letters making Australian men disappear Read more
Access to Breo Ellipta for respiratory patients on the PBS is unchanged
GSK’s respiratory medicine Breo Ellipta (fluticasone furoate/vilanterol trifenatate 100/25mcg and 200/25mcg) continues to be available to appropriate patients with asthma and COPD on the PBS.
Read more - Access to Breo Ellipta for respiratory patients on the PBS is unchanged Read more
GSK confirms that Bexsero (meningococcal B vaccine) will be available for purchase in Australia next week
GSK transfers Ultiva to Aspen in Australia
Read more - GSK transfers Ultiva to Aspen in Australia Read more
Bexsero (meningococcal B) vaccine availability
Read more - Bexsero (meningococcal B) vaccine availability Read more
Collaboration and mentorship prove winning formula for manufacturing
Read more - Collaboration and mentorship prove winning formula for manufacturing Read more
GSK welcomes Medicines Australia strategic agreement
Read more - GSK welcomes Medicines Australia strategic agreement Read more
GSK Australia Reports 2016 results to ASIC
Read more - GSK Australia Reports 2016 results to ASIC Read more
Statement on arachnoiditis and myelograms
GSK has the utmost sympathy for the people who have been, and are, afflicted by arachnoiditis. It can be a very debilitating and painful condition.
Arachnoiditis has a range of possible causes such as spinal injury, surgery and infection. However, it is difficult to determine the causality of arachnoiditis.
Read more - Statement on arachnoiditis and myelograms Read more
